Bacterial delivery of Staphylococcus aureus α-hemolysin causes regression and necrosis in murine tumors.
Ontology highlight
ABSTRACT: Bacterial therapies, designed to manufacture therapeutic proteins directly within tumors, could eliminate cancers that are resistant to other therapies. To be effective, a payload protein must be secreted, diffuse through tissue, and efficiently kill cancer cells. To date, these properties have not been shown for a single protein. The gene for Staphylococcus aureus α-hemolysin (SAH), a pore-forming protein, was cloned into Escherichia coli. These bacteria were injected into tumor-bearing mice and volume was measured over time. The location of SAH relative to necrosis and bacterial colonies was determined by immunohistochemistry. In culture, SAH was released and killed 93% of cancer cells in 24 hours. Injection of SAH-producing bacteria reduced viable tissue to 9% of the original tumor volu
SUBMITTER: St Jean AT
PROVIDER: S-EPMC4089002 | biostudies-literature | 2014 Jul
REPOSITORIES: biostudies-literature
ACCESS DATA